Fact CheckerSign in

NCT00568997Active, not recruiting

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)

Source: ClinicalTrials.gov · Last updated 16 Sept 2025

Brief summary (registry, in English)

This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
8000 (estimated)
First submitted
5 Dec 2007
Start date
27 Jun 2005
Primary completion date
31 Dec 2027
Lead sponsor
Bausch Health Americas, Inc.
NCT number
NCT00568997

What you commit to

  • Study type: Observational
  • Planned participants: 8000
  • From 27 Jun 2005 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • past or present use of oral immunosuppressive therapy

Other illness

  • past or present history of systemic malignancy, skin malignancy, or lymphoproliferative disease

Who the study is looking for

  • males and females
  • greater than or equal to 2 years and less than or equal to 17 years at enrollment
  • diagnosis of atopic dermatitis (confirmed by treating physician)
  • applied pimecrolimus cream 1 % 6 weeks out of past 24 weeks

Age in the registry: 2 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Registry
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.